Picture of HAVN Life Sciences logo

HAVN HAVN Life Sciences Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-3.03%
3m+43.39%
6m-39.95%
1yr-66.73%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-1779.71%
Return on Equity-234.52%
Operating Margin-2619.63%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Apr 202330th Apr 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of HAVN Life Sciences EPS forecast chart

Profile Summary

HAVN Life Sciences Inc. is a Canada-based biotechnology company. The Company is engaged in the scientific research and development of psychopharmacological and natural health care products. It is focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities of the mind. The Company has two business divisions: HAVN Labs and HAVN Retail. The HAVN Labs division is engaged in the development of research protocols to cover the production of Psilocybe spp. Through its research division, HAVN Labs, it has developed an end-to-end supply chain of GMP naturally derived psychedelic compounds for research. The HAVN Retail division formulates and sells natural health products (NHPs) using compounds. It offers a full range of mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.

Directors

    Last Annual
    April 30th, 2022
    Last Interim
    January 31st, 2023
    Incorporated
    April 8th, 2020
    Public Since
    September 8th, 2020
    No. of Employees
    6
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    ca flag iconCanadian Securities Exchange
    Shares in Issue
    28,646,020

    HAVN Share Price Performance

    Upcoming Events for HAVN

    Q2 2024 HAVN Life Sciences Inc Earnings Release

    Q3 2024 HAVN Life Sciences Inc Earnings Release

    Similar to HAVN

    Picture of Albert Labs International logo

    Albert Labs International

    ca flag iconCanadian Securities Exchange

    Picture of Algernon Pharmaceuticals logo

    Algernon Pharmaceuticals

    ca flag iconCanadian Securities Exchange

    Picture of Alpha Cognition logo

    Alpha Cognition

    ca flag iconCanadian Securities Exchange

    Picture of Asep Medical Holdings logo

    Asep Medical Holdings

    ca flag iconCanadian Securities Exchange

    Picture of Awakn Life Sciences logo

    Awakn Life Sciences

    ca flag iconCanadian Securities Exchange

    FAQ